Inflammatory linear verrucous epidermal nevus

Editor-In-Chief: Prab R Tumpati, MD
Obesity, Sleep & Internal medicine
Founder, WikiMD Wellnesspedia &
W8MD's weight loss doctor NYC
Philadelphia GLP-1 weight loss and GLP-1 clinic NYC
| Inflammatory linear verrucous epidermal nevus | |
|---|---|
| Synonyms | ILVEN |
| Pronounce | N/A |
| Specialty | Dermatology |
| Symptoms | Pruritus, verrucous papules |
| Complications | N/A |
| Onset | Childhood |
| Duration | Chronic |
| Types | N/A |
| Causes | Genetic mutation |
| Risks | Family history |
| Diagnosis | Clinical diagnosis, skin biopsy |
| Differential diagnosis | Psoriasis, linear epidermal nevus |
| Prevention | N/A |
| Treatment | Topical corticosteroids, retinoids, laser therapy |
| Medication | N/A |
| Prognosis | N/A |
| Frequency | Rare |
| Deaths | N/A |
Alternate names[edit]
ILVEN; Linear verrucose epidermal nevus; Verrucous epidermal nevus; Verrucous nevus; Inflammatory linear verrucous epidermal naevus; Inflammatory linear verrucous epidermal nevus
Definition[edit]
Inflammatory linear verrucous epidermal nevus (ILVEN) is a type of skin overgrowth, called epidermal nevus.
Genetics[edit]
ILVEN is caused by a genetic change that occurs after conception (somatic mutation).
Signs and symptoms[edit]
- It is characterized by skin colored, brown, or reddish, wart-like papules (nevi).
- The nevi join to form patches or plaques that often follow a pattern on the skin known as the "lines of Blaschko".
- The affected areas of the skin may be red, itchy, and inflamed.
- ILVEN typically presents from birth to early childhood and often is limited to one side of the lower half of the body.
- It affects females more often than males.
- It usually occurs alone; however, rarely ILVEN can be associated with other symptoms as part of an epidermal nevus syndrome.
- Rarely, ILVEN can become cancerous (for example, basal cell carcinoma or squamous cell carcinoma).
Diagnosis[edit]
- A diagnosis of ILVEN syndrome should be considered in patients with extensive verrucous, pruritic epidermal nevi, and/or systemic abnormalities.
- A thorough mucocutaneous, neurologic, ophthalmic, and orthopedic examination is necessary with specific investigations depending on the involved system.
- A regular follow-up is necessary due to the risk of malignant transformation of the nevi and development of systemic manifestations.[1].
Treatment[edit]
- There is no one treatment or cure for ILVEN. Products used to soften the skin (emollients), moisturizers, and topical steroids may be utilized to relieve symptoms of dryness and itching.
- Recently, several patients have been treated with laser therapy with good results.
- ↑ Kumar, C. A., Yeluri, G., & Raghav, N. (2012). Inflammatory linear verrucous epidermal nevus syndrome with its polymorphic presentation - A rare case report. Contemporary clinical dentistry, 3(1), 119–122. https://doi.org/10.4103/0976-237X.94562
| Diseases of the skin and appendages by morphology | ||||||||||||||||||||||||||||||||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
| Skin cancer of the epidermis | ||||||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
NIH genetic and rare disease info[edit]
Inflammatory linear verrucous epidermal nevus is a rare disease.
| Rare and genetic diseases | ||||||
|---|---|---|---|---|---|---|
|
Rare diseases - Inflammatory linear verrucous epidermal nevus
|
Sponsored Health Resource

W8MD Weight Loss, Sleep & MedSpa
Looking for physician-supervised weight loss, semaglutide, tirzepatide, or GLP-1 receptor agonist options? W8MD helps eligible patients in New York City, Brooklyn, New Jersey, Connecticut, Pennsylvania, Delaware, and greater Philadelphia with medical weight loss, sleep medicine, and long-term maintenance support.
GLP-1 specials: Affordable GLP-1 injections NYC and Philadelphia starting from $29.99/week and up for semaglutide with insurance accepted for qualifying visits, and $45/week and up for tirzepatide with insurance accepted for qualifying visits. Self-pay options start from $59.99/week and up for semaglutide and $69.99/week and up for tirzepatide.
- Medical weight loss NYC
- Affordable GLP-1 injections NYC
- Budget GLP-1 weight loss shots Philadelphia
- New Jersey medical weight loss
- NYC medical weight loss blog
- Philadelphia weight loss blog
- Sleep medicine and sleep apnea services
- W8MD MedSpa and wellness
Book a W8MD appointment · View GLP-1 specials
Paid promotional message. Eligibility, pricing, insurance coverage, medication availability, and results vary. Medical evaluation required.
Medical Disclaimer: WikiMD is for informational purposes only and is not a substitute for professional medical advice. Content may be inaccurate or outdated and should not be used for diagnosis or treatment. Always consult your healthcare provider for medical decisions. Verify information with trusted sources such as CDC.gov and NIH.gov. By using this site, you agree that WikiMD is not liable for any outcomes related to its content. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.
Translate page: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian

